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background:  Although guidelines for antiarrhythmic drug (AAD) therapy in atrial fibrillation (AF) were published in 2006, it remains 
uncertain whether adherence to these guidelines affects patient outcome. 
Methods:  We evaluated the records of 5,976 AF patients who were prescribed at least one AAD between 2006 and 2013 at our institution. 
Patients with one or more prescribed AAD that is not compliant with guidelines constituted the noncompliant group (NC=2,921) while the 
rest the compliant group (CO=3,055). Time to events was assessed using the KM method and adjusted for unbalanced covariates using a 
Cox regression model. 
results:  The 2 groups had differences in their baseline CHADS2-vasc scores (p=0.001) and their rates of heart failure, coronary and 
valvular heart disease, hypertension, diabetes, pulmonary and renal disease (p<0.05 for all comparisons). During 45±26 months of follow-
up, although the risk of death was similar between the 2 groups (HR=0.96, p=0.56), the CO group had less AF recurrence (hazard ratio 
(HR) =0.84, p<0.001), less hospital admissions for AF (HR=0.87, p=0.015), and less electric cardioversions for AF (HR=0.81, p=0.002). 
Conclusion:  Adherence to published guidelines in the anti-arrhythmic management of AF is associated with improved patient outcomes.
 
